ArticleBMJ public health2026
Assessing the effectiveness of seasonal malaria chemoprevention on malaria burden among children under 5 in northern Benin: a statistical modelling approach.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Children under 5 in northern Benin remain highly vulnerable to malaria infection. Seasonal malaria chemoprevention (SMC), implemented since 2019, shows promise in reducing this burden. However, current malaria funding cuts threaten its future implementation putting additional children's lives at risk. Generating evidence about SMC's effectiveness is therefore crucial to support continued implementation. Methods: A quasi-experimental analysis evaluated SMC's impact on malaria morbidity in children under 5 during 2019-2022. Routine malaria indicators retrieved from the Health Management Information System from six SMC-treated health zones (HZs) were compared against synthetic counterfactuals constructed using nine eligibles untreated HZs. Synthetic control methods identified control HZs best matching intervention HZs on pre-intervention (2017-2018) characteristics (rainfall, temperature, relative humidity), with pre-intervention fit assessed using root mean square prediction error. Generalised linear mixed models then estimated SMC effects on uncomplicated and severe malaria incidences, accounting for reporting bias, other interventions and key environmental factors. Results: Following SMC implementation, severe malaria incidence decreased by 41% in the intervention group (incidence rate ratio (IRR): 0.59, 95% CI 0.44 to 0.79) but increased by 26% in the control group (IRR: 1.30, 95% CI 0.97 to 1.63). Although uncomplicated malaria incidence rose in both groups, the increase was significantly lower in the SMC group (2.49%) compared with the control (16.3%). The ratio of IRR in the intervention versus control HZs was 78% (95% CI 63% to 96%, p=0.004) for uncomplicated malaria and 47% (95% CI 30% to 74%, p<0.001) for severe malaria, confirming a protective effect of SMC on both outcomes. Conclusions: These findings strongly support continuing SMC implementation in northern Benin and its geographical expansion to eligible HZs not yet covered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.